12th International Forum on
Maximising Pharma Patents
Tuesday, June 25 to Wednesday, June 26, 2013
Kensington Close Hotel, London
Strategies to maximise pharma patents will be significantly transformed. In February 2013 the European Commission will be publishing final draft rules on unitary patent and the unified patents court. Understanding the new legal regime and how these changes will affect pharma patent is essential for the pharma industry.
The 12th International Forum on Maximising Pharma Patents will bring together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert advisors from a range of jurisdictions, including the US, Europe and Asia. A special keynote address will be given by leading judge on the unitary patent and the unified patents court.
The forum will include analysis of new procedural rules published by the European Commission on unitary patent and its impact on pharma patent management. Panel speakers will be leading judges, regulatory experts, and industry specialists speaking on how it will work in practice.
Judicial authorities will speak on SPC procedures, recent cases referred to the European Court of Justice on the scope of SPCs and the impact of the pending decisions for pharma patent extensions. Based on their first-hand experience, the distinguished panel will provide you with invaluable information and insights on pharma patent with a particular focus on:
Be where your industry will be on 25th and 26th June 2013 and don’t miss out on this unique opportunity to hear from and network with prominent judicial authorities, regulatory experts and industry specialists.
For sponsorship opportunities please contact :
For media partnership opportunities please contact:
- click image for pdf -
- Actions -
- Share -
Tue, Jun 25, 2013
Wed, Jun 26, 2013
Kensington Close Hotel